Henrik Wiggers

Advance care planning and place of death, hospitalisation and actual place of death in lung, heart and cancer disease: a randomised controlled trial

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Standard

Advance care planning and place of death, hospitalisation and actual place of death in lung, heart and cancer disease : a randomised controlled trial. / Skorstengaard, Marianne Hjorth; Jensen, Anders Bonde; Andreassen, Pernille; Brogaard, Trine; Bendstrup, Elisabeth; Løkke, Anders; Aagaard, Susanne; Wiggers, Henrik; Neergaard, Mette Asbjoern.

In: BMJ Supportive & Palliative Care, 11.04.2019.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{911b42e37141491ebabc0c5329c9f792,
title = "Advance care planning and place of death, hospitalisation and actual place of death in lung, heart and cancer disease: a randomised controlled trial",
abstract = "OBJECTIVES: Advance care planning (ACP) can be a way to meet patients' end-of-life preferences and enhance awareness of end-of-life care. Thereby it may affect actual place of death (APOD) and decrease the rate of hospitalisations. The aim was to investigate if ACP among terminally ill patients with lung, heart and cancer diseases effects fulfilment of preferred place of death (PPOD), amount of time spent in hospital and APOD.METHODS: The study was designed as a randomised controlled trial. Patients were assessed using general and disease-specific criteria and randomised into groups: one received usual care and one received usual care plus ACP. The intervention consisted of a discussion between a healthcare professional, the patient and their relatives about preferences for end-of-life care. The discussion was documented in the hospital file.RESULTS: In total, 205 patients were randomised, of which 111 died during follow-up. No significant differences in fulfilment of PPOD (35{\%} vs 52{\%}, p=0.221) or in amount of time spent in hospital among deceased patients (49{\%} vs 23{\%}, p=0.074) were found between groups. A significant difference in APOD was found favouring home death in the intervention group (17{\%} vs 40{\%}, p=0.013).CONCLUSION: Concerning the primary outcome, fulfilment of PPOD, and the secondary outcome, time spent in hospital, no differences were found. A significant difference concerning APOD was found, as more patients in the intervention group died at home, compared with the usual care group.TRIAL REGISTRATION NUMBER: NCT01944813.",
author = "Skorstengaard, {Marianne Hjorth} and Jensen, {Anders Bonde} and Pernille Andreassen and Trine Brogaard and Elisabeth Bendstrup and Anders L{\o}kke and Susanne Aagaard and Henrik Wiggers and Neergaard, {Mette Asbjoern}",
note = "{\circledC} Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.",
year = "2019",
month = "4",
day = "11",
doi = "10.1136/bmjspcare-2018-001677",
language = "English",
journal = "BMJ Supportive & Palliative Care",
issn = "2045-435X",
publisher = "BMJ Group",

}

RIS

TY - JOUR

T1 - Advance care planning and place of death, hospitalisation and actual place of death in lung, heart and cancer disease

T2 - a randomised controlled trial

AU - Skorstengaard, Marianne Hjorth

AU - Jensen, Anders Bonde

AU - Andreassen, Pernille

AU - Brogaard, Trine

AU - Bendstrup, Elisabeth

AU - Løkke, Anders

AU - Aagaard, Susanne

AU - Wiggers, Henrik

AU - Neergaard, Mette Asbjoern

N1 - © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

PY - 2019/4/11

Y1 - 2019/4/11

N2 - OBJECTIVES: Advance care planning (ACP) can be a way to meet patients' end-of-life preferences and enhance awareness of end-of-life care. Thereby it may affect actual place of death (APOD) and decrease the rate of hospitalisations. The aim was to investigate if ACP among terminally ill patients with lung, heart and cancer diseases effects fulfilment of preferred place of death (PPOD), amount of time spent in hospital and APOD.METHODS: The study was designed as a randomised controlled trial. Patients were assessed using general and disease-specific criteria and randomised into groups: one received usual care and one received usual care plus ACP. The intervention consisted of a discussion between a healthcare professional, the patient and their relatives about preferences for end-of-life care. The discussion was documented in the hospital file.RESULTS: In total, 205 patients were randomised, of which 111 died during follow-up. No significant differences in fulfilment of PPOD (35% vs 52%, p=0.221) or in amount of time spent in hospital among deceased patients (49% vs 23%, p=0.074) were found between groups. A significant difference in APOD was found favouring home death in the intervention group (17% vs 40%, p=0.013).CONCLUSION: Concerning the primary outcome, fulfilment of PPOD, and the secondary outcome, time spent in hospital, no differences were found. A significant difference concerning APOD was found, as more patients in the intervention group died at home, compared with the usual care group.TRIAL REGISTRATION NUMBER: NCT01944813.

AB - OBJECTIVES: Advance care planning (ACP) can be a way to meet patients' end-of-life preferences and enhance awareness of end-of-life care. Thereby it may affect actual place of death (APOD) and decrease the rate of hospitalisations. The aim was to investigate if ACP among terminally ill patients with lung, heart and cancer diseases effects fulfilment of preferred place of death (PPOD), amount of time spent in hospital and APOD.METHODS: The study was designed as a randomised controlled trial. Patients were assessed using general and disease-specific criteria and randomised into groups: one received usual care and one received usual care plus ACP. The intervention consisted of a discussion between a healthcare professional, the patient and their relatives about preferences for end-of-life care. The discussion was documented in the hospital file.RESULTS: In total, 205 patients were randomised, of which 111 died during follow-up. No significant differences in fulfilment of PPOD (35% vs 52%, p=0.221) or in amount of time spent in hospital among deceased patients (49% vs 23%, p=0.074) were found between groups. A significant difference in APOD was found favouring home death in the intervention group (17% vs 40%, p=0.013).CONCLUSION: Concerning the primary outcome, fulfilment of PPOD, and the secondary outcome, time spent in hospital, no differences were found. A significant difference concerning APOD was found, as more patients in the intervention group died at home, compared with the usual care group.TRIAL REGISTRATION NUMBER: NCT01944813.

U2 - 10.1136/bmjspcare-2018-001677

DO - 10.1136/bmjspcare-2018-001677

M3 - Journal article

JO - BMJ Supportive & Palliative Care

JF - BMJ Supportive & Palliative Care

SN - 2045-435X

ER -